Article
Patient-Reported Outcome Measures may optimize shared decision-making for cancer risk management in BRCA mutation carriers.
Breast cancer (Tokyo, Japan) - 1 May 2020
van Egdom L S E, de Kock M A, Apon I, Mureau M A M, Verhoef C, Hazelzet J A, Koppert L B
Abstract excerpt
PURPOSE: The aim of this study was to compare patient-reported outcomes (PROs) of BRCA1/2 mutation carriers, either after bilateral prophylactic mastectomy (BPM) or during breast surveillance, to improve shared decision-making in their cancer risk management. METHODS: Unaffected BRCA1/2 mutation carriers at least one year after BPM followed by immediate breast reconstruction (BPM-IBR) or one year under...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
